Publicacións en colaboración con investigadores/as de St George's, University of London (24)

2024

  1. Targeted metagenomics reveals association between severity and pathogen co-detection in infants with respiratory syncytial virus

    Nature Communications, Vol. 15, Núm. 1

2023

  1. The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study

    The Lancet Respiratory Medicine, Vol. 11, Núm. 4, pp. 341-353

  2. Trends in eczema prevalence in children and adolescents: A Global Asthma Network Phase I Study

    Clinical and Experimental Allergy, Vol. 53, Núm. 3, pp. 337-352

2022

  1. Children living with HIV in Europe: do migrants have worse treatment outcomes?

    HIV Medicine, Vol. 23, Núm. 2, pp. 186-196

  2. Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)

    Expert Review of Anti-Infective Therapy, Vol. 20, Núm. 3, pp. 445-456

  3. The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study

    European Respiratory Journal, Vol. 60, Núm. 3

  4. Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I

    Pediatric Allergy and Immunology, Vol. 33, Núm. 1

2021

  1. Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control study

    BMJ Open Respiratory Research, Vol. 8, Núm. 1

  2. Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

    Nature Communications, Vol. 12, Núm. 1

  3. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 232-241

  4. Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus (Nature Communications, (2021), 12, 1, (5125), 10.1038/s41467-021-25265-4)

    Nature Communications

  5. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

    Obstetrical and Gynecological Survey

  6. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

    The Lancet, Vol. 398, Núm. 10311, pp. 1569-1580

2020

  1. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination

    Journal of Infection, Vol. 81, Núm. 4, pp. 483-498

2019

  1. Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study

    Epilepsia Open, Vol. 4, Núm. 1, pp. 73-84

  2. Newly diagnosed and growing subependymal giant cell astrocytoma in adults with tuberous sclerosis complex: Results from the International TOSCA Study

    Frontiers in Neurology, Vol. 10, Núm. JUL

  3. Priority Needs for Conducting Pandemic-relevant Clinical Research with Children in Europe: A Consensus Study with Pediatric Clinician-researchers

    Pediatric Infectious Disease Journal, Vol. 38, Núm. 5, pp. E82-E86

2016

  1. Meeting report: Harmonization of RSV therapeutics - from design to performance

    Journal of Global Health, Vol. 6, Núm. 1

  2. Persistence of bactericidal antibodies after infant serogroup B meningococcal immunization and booster dose response at 12, 18 or 24 months of age

    Pediatric Infectious Disease Journal

2015

  1. Lower respiratory tract infection caused by respiratory syncytial virus: Current management and new therapeutics

    The Lancet Respiratory Medicine, Vol. 3, Núm. 11, pp. 888-900